JP2023501577A5 - - Google Patents
Info
- Publication number
- JP2023501577A5 JP2023501577A5 JP2022527717A JP2022527717A JP2023501577A5 JP 2023501577 A5 JP2023501577 A5 JP 2023501577A5 JP 2022527717 A JP2022527717 A JP 2022527717A JP 2022527717 A JP2022527717 A JP 2022527717A JP 2023501577 A5 JP2023501577 A5 JP 2023501577A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- compound
- membered
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025135739A JP2025161894A (ja) | 2019-11-13 | 2025-08-18 | ５－ヒドロキシトリプタミン受容体７の調節因子としての新規官能化ラクタムおよびその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962934997P | 2019-11-13 | 2019-11-13 | |
| US62/934,997 | 2019-11-13 | ||
| PCT/US2020/060270 WO2021097116A1 (en) | 2019-11-13 | 2020-11-12 | Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025135739A Division JP2025161894A (ja) | 2019-11-13 | 2025-08-18 | ５－ヒドロキシトリプタミン受容体７の調節因子としての新規官能化ラクタムおよびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023501577A JP2023501577A (ja) | 2023-01-18 |
| JP2023501577A5 true JP2023501577A5 (https=) | 2023-11-20 |
| JP7730811B2 JP7730811B2 (ja) | 2025-08-28 |
Family
ID=74068668
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022527717A Active JP7730811B2 (ja) | 2019-11-13 | 2020-11-12 | ５－ヒドロキシトリプタミン受容体７の調節因子としての新規官能化ラクタムおよびその使用方法 |
| JP2025135739A Pending JP2025161894A (ja) | 2019-11-13 | 2025-08-18 | ５－ヒドロキシトリプタミン受容体７の調節因子としての新規官能化ラクタムおよびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025135739A Pending JP2025161894A (ja) | 2019-11-13 | 2025-08-18 | ５－ヒドロキシトリプタミン受容体７の調節因子としての新規官能化ラクタムおよびその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230002383A1 (https=) |
| EP (1) | EP4058455A1 (https=) |
| JP (2) | JP7730811B2 (https=) |
| KR (1) | KR20220113702A (https=) |
| CN (1) | CN115003675A (https=) |
| AU (1) | AU2020381460A1 (https=) |
| BR (1) | BR112022009374A2 (https=) |
| CA (1) | CA3160801A1 (https=) |
| IL (1) | IL292811A (https=) |
| MX (1) | MX2022005820A (https=) |
| TW (1) | TWI905129B (https=) |
| WO (1) | WO2021097116A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA49019A (fr) | 2017-03-21 | 2020-02-05 | Univ Temple | Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation |
| EA202092328A1 (ru) | 2018-05-11 | 2021-04-08 | Темпл Юниверсити-Оф Зэ Коммонвелс Систем Оф Хаер Эдьюкейшн | Новые функционализированные лактамы в качестве модуляторов 5-гидрокситриптаминового рецептора 7 и способ их применения |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201002563D0 (en) * | 2010-02-15 | 2010-03-31 | Cambridge Entpr Ltd | Compounds |
| WO2014164756A1 (en) * | 2013-03-11 | 2014-10-09 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| WO2016040554A1 (en) * | 2014-09-10 | 2016-03-17 | Temple University-Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| IL309982A (en) * | 2016-11-15 | 2024-03-01 | Univ Temple | New modulators of 5-hydroxytryptamine receptor 7 and a method of using them |
| JP7365238B2 (ja) | 2017-03-21 | 2023-10-19 | テンプル・ユニバーシティ－オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | ５－ヒドロキシトリプタミン受容体７調節物質および治療剤としてのその使用 |
| WO2019094856A1 (en) * | 2017-11-13 | 2019-05-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Atypical inhibitors of monoamine transporters; method of making; and use thereof |
| EA202092328A1 (ru) * | 2018-05-11 | 2021-04-08 | Темпл Юниверсити-Оф Зэ Коммонвелс Систем Оф Хаер Эдьюкейшн | Новые функционализированные лактамы в качестве модуляторов 5-гидрокситриптаминового рецептора 7 и способ их применения |
-
2020
- 2020-11-12 CA CA3160801A patent/CA3160801A1/en active Pending
- 2020-11-12 MX MX2022005820A patent/MX2022005820A/es unknown
- 2020-11-12 JP JP2022527717A patent/JP7730811B2/ja active Active
- 2020-11-12 EP EP20829736.6A patent/EP4058455A1/en active Pending
- 2020-11-12 AU AU2020381460A patent/AU2020381460A1/en active Pending
- 2020-11-12 US US17/776,533 patent/US20230002383A1/en active Pending
- 2020-11-12 CN CN202080093159.6A patent/CN115003675A/zh active Pending
- 2020-11-12 BR BR112022009374A patent/BR112022009374A2/pt unknown
- 2020-11-12 KR KR1020227019540A patent/KR20220113702A/ko active Pending
- 2020-11-12 WO PCT/US2020/060270 patent/WO2021097116A1/en not_active Ceased
- 2020-11-13 TW TW109139761A patent/TWI905129B/zh active
-
2022
- 2022-05-07 IL IL292811A patent/IL292811A/en unknown
-
2025
- 2025-08-18 JP JP2025135739A patent/JP2025161894A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4792025B2 (ja) | ５−ヒドロキシインドール−３−カルボン酸エステル類誘導体およびその用途 | |
| RU2213743C2 (ru) | Производное тиенилазолилалкоксиэтанамина, способ его получения (варианты), фармацевтическая композиция, промежуточный продукт и способ его получения (варианты) | |
| ES2963111T3 (es) | Derivados de 4-(1,3,4-oxadiazol-2-il)piridina-2(1H)-ona como inhibidores de la histona desacetilasa 6 (HDAC6) para el tratamiento de infecciones E.G | |
| JP2005504039A5 (https=) | ||
| JP2000086657A (ja) | ５−アミノイソキサゾール誘導体 | |
| US7501424B2 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| ES2869229T3 (es) | Derivados de 2-(((pirrolidin-3-il)carbonil)amino)-1H-imidazol como agonistas del receptor de melanocortina 1 (MCR1) para tratar la artritis reumatoide | |
| JP2023501577A5 (https=) | ||
| FR2642759A1 (fr) | Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante | |
| US10947225B2 (en) | Phosphotidylinositol 3-kinase inhibitors | |
| JPWO2009041559A1 (ja) | インダゾールアクリル酸アミド化合物 | |
| KR20090016504A (ko) | 선택적 칸나비노이드 ｃｂ1 수용체 길항제로서의 황 함유 피라졸 유도체 | |
| AU2005266493B2 (en) | Inhibitors of Hsp90 | |
| CA2547391A1 (fr) | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament | |
| JP4464560B2 (ja) | 置換イソインドロンおよび医薬におけるサイクリックｇｍｐ調節剤としてのそれらの使用 | |
| CN1455770A (zh) | (2－氮杂二环[2.2.1]庚烷－7－基)甲醇衍生物作为烟碱类乙酰胆碱受体激动剂 | |
| WO2019065794A1 (ja) | Ｐａｃ１受容体拮抗薬を用いた鎮痛薬 | |
| JP2023501576A5 (https=) | ||
| US9381260B2 (en) | Hypoxia inducible factor-1 pathway inhibitors and uses as anticancer and imaging agents | |
| US9751825B2 (en) | TAK1 kinase inhibitors, compositions, and used related thereto | |
| JP2023551313A (ja) | アミド化合物、医薬組成物およびその使用 | |
| EP0853479A1 (en) | ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS | |
| CN101821254B (zh) | 肾上腺素能化合物 | |
| JP2001519828A (ja) | α▲下２▼−アドレナリン受容体作動薬として有用な５−（２−イミダゾリニルアミノ）ベンゾイミダゾール化合物類 | |
| FR2877005A1 (fr) | Nouveaux derives d'arylpiperazine |